The OLS has just launched the Biomanufacturing Fund (BMF) to support life science companies investing in manufacturing projects in the UK. The BMF will provide up to £38 million in capital grants to incentivise investment in the manufacture of vaccines and biotherapeutics, to improve the UK’s health resilience for future pandemics.
The BMF follows on from the £60m Life Sciences Innovative Manufacturing Fund (LSIMF) and will be using the same process as LSIMF for delivering the grants.
There are two upcoming opportunities to apply, with monthly deadlines of 30th June and 31st July. If you think you could benefit from this fund please contact the BMF team at bmf@officeforlifesciences.gov.uk You can find out more details about the fund at this webpage
Read our other news
Urenco Group upbeat as revenues dip but order book increases
Read More
Revenue fell at uranium enrichment services provider Urenco Group in its most recent financial year, but its order book jumped 27 per cent to more than €18bn
Former Chester Argos store to be turned into 24-hour gym with cafe
Read More
Former Chester Argos store to be turned into 24-hour gym with cafe
Cheshire housing trust welcomes new finance director
Read More
A Northwich-based housing association has appointed a new finance director